Dravet Syndrome (SCN1A mutations) and Rett Syndrome (Mecp2 and CDKL5 mutations) are among the most studied syndromes related to epilepsy using this technology [59–66]. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.